XML 15 R4.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)        
Revenue $ 2,582 $ 561 $ 4,778 $ 1,041
Operating expenses        
Direct costs 2,987 540 5,017 1,055
Research and development 8,440 3,203 15,101 6,309
Marketing and sales 957 535 1,752 1,090
General and administrative 4,894 2,332 8,918 2,929
Total operating expenses 17,278 6,610 30,788 11,383
Operating loss (14,696) (6,049) (26,010) (10,342)
Non-operating income (expense)        
Interest income 735 9 936 9
Interest expense (5) (121) (10) (342)
Other income (expense) 196 (3,100) 235 (3,100)
Change in fair value of warrant liabilities 27,473   28,183  
Loss from change in fair value of embedded derivative liability       (2,680)
Total non-operating income (expense) 28,399 (3,212) 29,344 (6,113)
Pretax income (loss) 13,703 (9,261) 3,334 (16,455)
Income tax expense (benefit) 36 12 13 (41)
Net income (loss) 13,667 (9,273) 3,321 (16,414)
Other comprehensive loss (961)   (1,291)  
Comprehensive income (loss) attributable to common stockholders $ 12,706 $ (9,273) $ 2,030 $ (16,414)
Basic earnings (loss) per share $ 0.08 $ (0.10) $ 0.02 $ (0.21)
Diluted earnings (loss) per share $ 0.08 $ (0.10) $ 0.02 $ (0.21)
Weighted average shares outstanding - basic 174,128,230 88,944,577 173,266,760 79,568,181
Weighted average shares outstanding - diluted 174,703,533 88,944,577 173,566,001 79,568,181